HEPATOPROTECTIVE EFFECT OF BPC 157, A 15-AMINO-ACID PEPTIDE, ON LIVER-LESIONS INDUCED BY EITHER RESTRAINT STRESS OR BILE-DUCT AND HEPATIC-ARTERY LIGATION OR CCL4 ADMINISTRATION - A COMPARATIVE-STUDY WITH DOPAMINE AGONISTS AND SOMATOSTATIN
P. Sikiric et al., HEPATOPROTECTIVE EFFECT OF BPC 157, A 15-AMINO-ACID PEPTIDE, ON LIVER-LESIONS INDUCED BY EITHER RESTRAINT STRESS OR BILE-DUCT AND HEPATIC-ARTERY LIGATION OR CCL4 ADMINISTRATION - A COMPARATIVE-STUDY WITH DOPAMINE AGONISTS AND SOMATOSTATIN, Life sciences, 53(18), 1993, pp. 291-296
The hepatoprotective effects of a newly synthesized 15 amino acid frag
ment code named BPC 157 was evaluated in comparison with the reference
standards (bromocriptine, amantadine and somatostatin) in various exp
erimental models of liver injury in rats: 24 h-bile duct + hepatic art
ery ligation 48 h-restraint stress and CCl4 administration. BPC 157 ad
ministered either intragastrically or intraperitoneally, significantly
prevented the development of liver necrosis or fatty changes in rats
subjected to 24 h bile duct + hepatic artery ligation, 48 h-restraint
stress, CCl4 treatment (1 ml/kg i.p., sacrifice 48 h thereafter). The
other reference drugs had either little or no protective actions in th
ese models. Noteworthy, the laboratory test results for bilirubin, SGO
T, SGPT fully correlated with the macro/microscopical findings. Thus,
on the basis of consistent protective effect of BPC 157, possible clin
ical application in liver diseases is now warranted.